Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly, Alexandra C. Greb, Lindsay P. Cameron, et al.
Cell Reports (2018) Vol. 23, Iss. 11, pp. 3170-3182
Open Access | Times Cited: 816

Showing 1-25 of 816 citing articles:

Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart‐Harris, Bruna Giribaldi, Rosalind Watts, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 15, pp. 1402-1411
Open Access | Times Cited: 987
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Robin Carhart‐Harris, Karl Friston
Pharmacological Reviews (2019) Vol. 71, Iss. 3, pp. 316-344
Open Access | Times Cited: 770
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects
David B. Yaden, Roland R. Griffiths
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 568-572
Open Access | Times Cited: 361
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao, Clara Liao, Ian Gregg, et al.
Neuron (2021) Vol. 109, Iss. 16, pp. 2535-2544.e4
Open Access | Times Cited: 359
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron, Robert J. Tombari, Ju Lu, et al.
Nature (2020) Vol. 589, Iss. 7842, pp. 474-479
Open Access | Times Cited: 335
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 284
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 155-166
Closed Access | Times Cited: 260
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave, Timothy A. Troppoli, Andreas B. Wulff, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 17
Open Access | Times Cited: 259
Psychedelic Psychiatry’s Brave New World
David Nutt, David Erritzøe, Robin Carhart‐Harris
Cell (2020) Vol. 181, Iss. 1, pp. 24-28
Open Access | Times Cited: 250
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
Maxemiliano V. Vargas, Lee E. Dunlap, Chunyang Dong, et al.
Science (2023) Vol. 379, Iss. 6633, pp. 700-706
Open Access | Times Cited: 242
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 563-567
Open Access | Times Cited: 237
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
Manoj K. Doss, Michal Považan, Monica D. Rosenberg, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 228
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 6, pp. 1032-1041
Open Access | Times Cited: 225
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Anne Katrin Schlag, Jacob S. Aday, Iram Salam, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 258-272
Open Access | Times Cited: 220
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Lukasz Smigielski, Milan Scheidegger, Michael Kometer, et al.
NeuroImage (2019) Vol. 196, pp. 207-215
Closed Access | Times Cited: 206
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 2003-2011
Open Access | Times Cited: 202
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze, Patrick Vizeli, Felix Müller, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 3, pp. 462-471
Open Access | Times Cited: 187
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Rafael G. dos Santos, José Carlos Bouso, Miguel Ángel Alcázar‐Córcoles, et al.
Expert Review of Clinical Pharmacology (2018) Vol. 11, Iss. 9, pp. 889-902
Closed Access | Times Cited: 186
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, et al.
Neuropharmacology (2020) Vol. 167, pp. 107933-107933
Open Access | Times Cited: 185
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
David E. Olson
Journal of Experimental Neuroscience (2018) Vol. 12
Open Access | Times Cited: 183
Long-term effects of psychedelic drugs: A systematic review
Jacob S. Aday, Cayla M. Mitzkovitz, Emily K. Bloesch, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 179-189
Closed Access | Times Cited: 183
Reviewing the Potential of Psychedelics for the Treatment of PTSD
Erwin Krediet, Tijmen Bostoen, Joost J. Breeksema, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 6, pp. 385-400
Open Access | Times Cited: 181
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Patrick Vizeli, Laura Ley, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 537-544
Open Access | Times Cited: 178
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
Page 1 - Next Page

Scroll to top